Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

This study has been terminated.
Sponsor:
Information provided by:
Oncology Specialties, Alabama
ClinicalTrials.gov Identifier:
NCT00232128
First received: October 3, 2005
Last updated: January 11, 2007
Last verified: May 2006

October 3, 2005
January 11, 2007
June 2003
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00232128 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Pulmonary Neoplasms
Procedure: Radiofrequency Ablation of pulmonary neoplasms
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
Not Provided
Not Provided
Not Provided

Inclusion Criteria: The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:

  1. unresectable primary or metastatic lung tumors
  2. may benefit from multiple modalities of therapy
  3. chemotherapeutic or radiation oncologic options have been exhausted

Exclusion Criteria:

1. co-existing morbidities that preclude the use of surgery

Both
19 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00232128
CCI LUN 02
Not Provided
Not Provided
Oncology Specialties, Alabama
Not Provided
Principal Investigator: Marshall T. Schreeder, M.D. Comprehensive Cancer Institute
Oncology Specialties, Alabama
May 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP